Prevalence of LUTS and Self Reported BPH and their Impact on Health Related Quality of Life of the Elderly
Abstract
Full Text:
PDFReferences
Guess HA. Epidemiology and natural history of benign prostatic hyperplasia. Urol Clin North Am1995; 22: 247±61
Birkhoff JD, Wiederhorn AR, Hamilton ML, Zinsser HH. Natural history of benign prostatic hypertrophy and acute urinary retention. Urology 1976; 7: 48±52
Barry MJ. Epidemiology and natural history of benign prostatic hyperplasia. Urol Clin North Am1990; 17: 495±507
Garraway WM, Collins GN, Lee RJ. High prevalence of benign prostatic hypertrophy in the community. Lancet 1991; 338: 469±71.
Oesterling JE. Benign prostatic hyperplasia. Medical and minimally invasive treatment options. N Engl J Med 1995; 332: 99±109
Simpson RJ, Fisher W, Lee AJ, Russell EB, Garraway M. Benign prostatic hyperplasia in an unselected community- based population: a survey of urinary symptoms, bothersomeness and prostatic enlargement. Br J Urol 1996; 77: 186±91
Bosch JL, Hop WC, Kirkels WJ, Schroder FH. Natural history of benign prostatic hyperplasia; appropriate case definition and estimation of its prevalence in the community. Urology 1995; 46: 34±40
Britton JP, Dowell AC, Whelan P. Prevalence of urinary symptoms in men over 60. Br J Urol 1990; 66: 175±6
Drummond MF, McGuire AJ, Black NA, Petticrew M, McPherson CK. Economic burden of treated benign prostatic hyperplasia in the United Kingdom. Br J Urol 1993; 71: 290±6
Oesterling JE. Benign prostatic hyperplasia: a review of its histogenesis and natural history. The Prostate (Suppl) 1996; 6:67±73
The EuroQol Group. EuroQol Ð a new facility for the measurement of health related quality of life. Health Policy 1990; 16: 199±208
Brazier J, Jones N, Kind P. Testing the validity of the EuroQo
l and comparing it with the SF- 36 health survey questionnaire. Qual Life Res 1993; 2: 167±8
Hurst NP, Kind P, Ruta D, Hunter M, Stubbings A. Measuring health related quality of life in rheumatoid arthritis: validity, responsiveness and reliability of EuroQol (EQ-5D). Br J Rheumatol 1997; 36: 551±9
Barry MJ, Fowler FJ Jr, O'Leary MP et al. The American Urological Association Symptom Index for benign prostatic hyperplasia. J Urol 1992; 148: 1549±57
Barry MJ, Fowler FJ, O'Leary MP et al. Correlation of the American Urological Association Symptom Index with self- administered versions of the Madsen-Iversen, Boyarsky and Maine Medical Assessment Program Indexes. J Urol 1992;148:1558±63
Cockett AT, Aso Y et al. Recommendation of the International Consensus Committee on prostate symptom score and quality of life assessment. In Cockett ATK, Khoury S, Aso Y et al., eds. Proceedings of the 2nd International Consultation on Benign Prostatic Hyperplasia (BPH) Paris: Scientific Communication International Ltd, 1994: 553±5
Homma Y, Kawabe K, Tsukamoto T et al. Epidemiologic survey of lower urinary tract symptoms in Asia and Australia using the International Prostate Symptom Score. Int J Urol 1997; 4: 40±6
Sagnier PP, Girman CJ, Garraway M et al. International comparison of the community prevalence of symptoms of prostatism in four countries. Eur Urol 1996; 29: 15±20.
Refbacks
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
An initiative of The Tamil Nadu Dr M.G.R. Medical University